Our findings suggest that glioma growth may be slowed dramatically through treatment with HDAC6 inhibitors that hinder the proliferation and promote the differentiation of tumor cells, and that these effects may be highly dependent on HDAC6 expression and cilia frequency in individual tumors. This evidence concerns the gene HDAC6 and glioma.